Göppner, D. et al. 2014. High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib. Acta Dermato-Venereologica. 94, 5 (Feb. 2014), 517–520. DOI:https://doi.org/10.2340/00015555-1813.